Annual Results Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
EQUITY AND LIABILITIES
No of Months
12
12
Share Capital
43.79
43.79
Share Warrants & Outstandings
Total Reserve
40.66
19.05
Shareholder's Funds
89.83
62.84
Minority Interest
0.00
0.00
Long-Term Borrowings
3.19
3.11
Secured Loans
2.51
1.64
Unsecured Loans
0.69
1.48
Deferred Tax Assets / Liabilities
1.19
3.41
Other Long Term Liabilities
0
0
Long Term Trade Payables
0.00
0.00
Long Term Provisions
0.11
0.13
Total Non-Current Liabilities
4.50
6.65
Current Liabilities
Trade Payables
10.06
9.22
Other Current Liabilities
3.66
4.12
Short Term Borrowings
1.83
1.06
Short Term Provisions
7.54
2.89
Total Current Liabilities
23.08
17.29
Total Liabilities
117.41
86.77
ASSETS
Non-Current Assets
0.00
0.00
Gross Block
49.19
43.42
Less: Accumulated Depreciation
27.47
24.03
Less : Impairment of Assets
0.00
0.00
Net Block
21.72
19.40
Lease Adjustment
0.00
0.00
Capital Work in Progress
11.91
1.95
Intangible assets under development
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
Assets in transit
0.00
0.00
Non Current Investments
0.03
0.00
Long Term Loans & Advances
0.00
0.00
Other Non Current Assets
0.00
0.00
Total Non-Current Assets
33.66
21.34
Current Assets Loans & Advances
Current Investments
0.00
0.00
Inventories
13.90
9.95
Sundry Debtors
22.95
8.77
Cash and Bank
5.92
12.12
Other Current Assets
29.52
18.80
Short Term Loans and Advances
11.47
15.79
Total Current Assets
83.75
65.43
Net Current Assets (Including Current Investments)
60.67
48.14
Total Current Assets Excluding Current Investments
83.75
65.43
Miscellaneous Expenses not written off
0.00
0.00
Total Assets
117.41
86.77
Contingent Liabilities
0.00
0.00
Total Debt
5.02
4.18
Book Value per share (adjusted)
1.93
1.44
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is 20.10% vs NA in Mar 2025
Other Long Term Liabilities
YoY Growth in year ended Mar 2026 is 0.00% vs NA in Mar 2025
Fixed Assets
YoY Growth in year ended Mar 2026 is 57.59% vs NA in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is 0.00% vs NA in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is 28.00% vs NA in Mar 2025
Compare Balance Sheet Results of Shukra Pharma.
Figures in Cr
Consolidated - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
43.79
24.70
19.09
77.29%
Share Warrants & Outstandings
Total Reserve
40.66
1,174.10
-1,133.44
-96.54%
Shareholder's Funds
89.83
1,198.80
-1,108.97
-92.51%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
3.19
373.10
-369.91
-99.15%
Secured Loans
2.51
373.10
-370.59
-99.33%
Unsecured Loans
0.69
0.00
0.69
0.00%
Deferred Tax Assets / Liabilities
1.19
4.30
-3.11
-72.33%
Other Long Term Liabilities
0.00
54.60
-54.60
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.11
55.70
-55.59
-99.80%
Total Non-Current Liabilities
4.50
487.70
-483.20
-99.08%
Current Liabilities
Trade Payables
10.06
266.50
-256.44
-96.23%
Other Current Liabilities
3.66
65.60
-61.94
-94.42%
Short Term Borrowings
1.83
307.50
-305.67
-99.40%
Short Term Provisions
7.54
39.30
-31.76
-80.81%
Total Current Liabilities
23.08
678.90
-655.82
-96.60%
Total Liabilities
117.41
2,365.40
-2,247.99
-95.04%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
49.19
2,331.20
-2,282.01
-97.89%
Less: Accumulated Depreciation
27.47
1,061.10
-1,033.63
-97.41%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
21.72
1,270.10
-1,248.38
-98.29%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
11.91
94.50
-82.59
-87.40%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.03
9.50
-9.47
-99.68%
Long Term Loans & Advances
0.00
43.50
-43.50
-100.00%
Other Non Current Assets
0.00
0.90
-0.90
-100.00%
Total Non-Current Assets
33.66
1,481.30
-1,447.64
-97.73%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
13.90
358.10
-344.20
-96.12%
Sundry Debtors
22.95
441.60
-418.65
-94.80%
Cash and Bank
5.92
13.80
-7.88
-57.10%
Other Current Assets
29.52
43.30
-13.78
-31.82%
Short Term Loans and Advances
11.47
27.30
-15.83
-57.99%
Total Current Assets
83.75
884.10
-800.35
-90.53%
Net Current Assets (Including Current Investments)
60.67
205.20
-144.53
-70.43%
Total Current Assets Excluding Current Investments
83.75
884.10
-800.35
-90.53%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
117.41
2,365.40
-2,247.99
-95.04%
Contingent Liabilities
0.00
64.10
-64.10
-100.00%
Total Debt
5.02
680.60
-675.58
-99.26%
Book Value per share (adjusted)
1.93
97.07
-95.14
-98.01%
Annual - Borrowings
Borrowings 5.02 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 20.10% vs NA in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.00 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 0.00% vs NA in Mar 2025
Annual - Fixed Assets
Fixed Assets 33.63 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 57.59% vs NA in Mar 2025
Annual - Investments
Investments 0.03 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 0.00% vs NA in Mar 2025
Annual - Current Assets
Current Assets 83.75 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 28.00% vs NA in Mar 2025
Footer loading
